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doi:10.1
1160Objective:We used a whole blood assay to characterize the immune system’s response after cardiopulmonary
bypass (CPB) in children to identify the risk for postoperative infections. We assessed the impact of CPB on
histone methylation as a potential mechanism for altering gene expression necessary for the immune system’s
capacity to defend against infections.
Methods:We prospectively enrolled patients less than 18 years old undergoing heart surgery requiring CPB at
C.S. Mott Children’s Hospital. Blood was obtained from patients before CPB, on CPB, and on postoperative
days 1, 3, and 5. Ex vivo lipopolysaccharide-induced tumor necrosis factor-alpha production measured the
capacity of the immune system. Serum cytokines were measured using a multiplex assay. Chromatin immuno-
precipitation to detect histone modifications at the interleukin (IL) 10 promoter was performed on circulating
mononuclear cells from a subgroup of patients.
Results: We enrolled 92 patients, and postoperative day 1 samples identified a subpopulation of immunocom-
petent patients at low risk for infections with a specificity of 93% (confidence interval [CI], 83%-98%) and
a negative predictive value of 88% (CI, 77%-95%; P ¼ .006). Patients classified as immunoparalyzed had
serum IL-10 levels 2.4-fold higher than the immunocompetent group (mean, 14.3  18.3 pg/mL vs 6.0  5.0
pg/mL; P¼ .01). In a subgroup of patients, we identified a greater percent of the ‘‘gene on’’ epigenetic signature,
H3K4me3, associated with the IL-10 promoter after CPB.
Conclusions: Our data demonstrate that immunophenotyping patients after CPB can predict their risk for the
development of postoperative infections. Novel mechanistic data suggest that CPB affects epigenetic alterations
in IL-10 gene regulation. (J Thorac Cardiovasc Surg 2012;143:1160-6)Supplemental material is available online.
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The Journal of Thoracic and Cardiovascular Sursurgical repair, and extended duration of mechanical venti-
lation.1-3 Circulating leukocytes, including peripheral blood
monocytes, are activated by the CPB circuit4 resulting in
a proinflammatory response that is responsible for the early
physiologic derangements observed after CPB. A compen-
satory anti-inflammatory response aimed at countering
proinflammation is necessary to reestablish homeostasis.
An exaggerated or prolonged anti-inflammatory response
can impair immune defense, rendering the host susceptible
to infections.
Increased investigation of the immunobiology of the
prolonged anti-inflammatory response has uncovered the
presence of ‘‘deactivated’’ peripheral blood monocytes
that have an attenuated response to ex vivo lipopolysaccha-
ride (LPS) challenge with tumor necrosis factor-alpha
(TNF-a) and a decrease in the cell surface major histocom-
patibility complex II molecule, human leukocyte antigen
(HLA) DR.5 The term ‘‘immunoparalysis’’ refers to the
combination of decreased ex vivo LPS responsiveness and
HLA-DR expression.6 The decrease in HLA-DR expression
on isolated monocytes resulting in an immunoparalyzed
state after CPB has been observed in children7 and is asso-
ciated with increased serum interleukin (IL) 10 levels.8
However, HLA-DR receptor expression denotes a pheno-
typic characteristic but does not reflect the functional capac-
ity of the innate immune system.gery c May 2012
Abbreviations and Acronyms
ChIP ¼ chromatin immunoprecipitation
CI ¼ confidence interval
CPB ¼ cardiopulmonary bypass
HLA ¼ human leukocyte antigen
IL ¼ interleukin
LPS ¼ lipopolysaccharide
RACHS-1 ¼ Risk Adjustment in Congenital
Heart Surgery
TNF-a ¼ tumor necrosis factor-alpha
Cornell et al Evolving Technology/Basic ScienceIn separate work examining patients with sepsis, the in-
flammatory response of sepsis is associated with significant
repression of many genes expressed by both innate and
adaptive immunity and increased expression of IL-10.9
Experimental data suggest such an expression pattern is me-
diated via epigenetically regulated histone methylation and
ultimately leads to an immunoparalyzed state.10
The aim of our study was to investigate the impact of
immunoparalysis after CPB in pediatric patients using
a functional ex vivo whole blood assay to immunopheno-
type, or stratify, patients. We further investigated the impact
of CPB on histone methylation at the IL-10 promoter as
a potential mechanistic contributor to immunoparalysis.E
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Patient Selection
This prospective cohort study was conducted at C.S. Mott Children’s
Hospital between September 2005 and March 2009 and was approved by
the Institutional Review Board. Patient information was de-identified con-
sistent with Health Insurance Portability and Accountability Act regula-
tions. Informed consent was obtained from parents of patients less than
18years of agebefore surgery. Patientswere excluded if theyhada diagnosis
consistent with immune suppression, an active infection as determined by
positive cultures before surgery, or no vascular access for blood sampling.
Anesthesia
Anesthesia was induced with sevoflurane. Neuromuscular blockadewas
achieved with pancruonium. Anesthesia was maintained throughout the
case with fentanyl and isoflurane. All patients received intraoperative anti-
biotics (cefazolin).
Cardiopulmonary Bypass
The CPB circuit was primed with Normosol solution (Hospira, Inc,
Lake Forest, Ill), colloid, sodium barcarbonate, mannitol (0.5 g/kg), and
heparin. For neonates and infants, packed red blood cells were added to
the circuit prime using white blood cell filters. Gas exchange was achieved
with a hollow-fiber membrane oxygenator in circuit with nonpulsatile oc-
clusive roller pumps. Pump flow was adjusted to keep systemic perfusion
pressures between 20 and 40 mm Hg for neonates and infants and between
30 and 50mmHg for older children. Full flow on CPBwas between 2.4 and
3.0 L $min1 $m2. The patient’s core temperaturewas controlled by a heat
exchanger in the CPB circuit and was monitored with esophageal, skin,
and rectal or bladder temperature probes. All patients received heparin
(400 IU/kg) before aortic cannulation.The Journal of Thoracic and CarClinical Data
Demographic data, duration of CPB, and intraoperative medications
were collected after arrival in the intensive care unit. Laboratory values,
medications, blood products, organ dysfunction scores, and culture results
were collected every morning for the duration of the intensive care unit
stay. Surgical complexity was determined by the Risk Adjustment in
Congenital Heart Surgery (RACHS-1) method.11,12 All blood transfusions
were infused using filters to prevent transmission of donor white blood
cells per hospital policy. The decision to send blood, urine, or sputum
samples to the laboratory for culture was made by the managing medical
team. For the purpose of this analysis, patients were classified as
‘‘infected’’ if any final culture report was positive and the patient received
a course of antibiotics for 5 or more days.
Ex Vivo LPS-Induced TNF-a Production
Whole blood samples were collected in heparinized tubes after anesthe-
sia induction but before incision (presample), at 1 hour after initiation of
CPB, or just before discontinuation of bypass if bypass was less than
1 hour (bypass sample), then as close to 8:00 AM as possible on postoper-
ative days 1, 3, and 5. Blood was not collected if arterial or central venous
access was removed or if the managing team determined the patient could
not tolerate additional blood sampling. Whole blood stimulation was
performed within 60 minutes of blood collection.
The whole blood assay has previously been described in detail.13 In
brief, 50 mL of heparinized whole blood was added to tubes of solution
(500 mL) containing 500 pg/mL of LPS from S. abortus equii (Sigma-Al-
drich, St Louis, Mo) and incubated at 37C for 4 hours. After centrifugation
at 10,000g for 5 minutes, the supernatants were stored at80C. Superna-
tants were shipped to the Immune Surveillance Laboratory at The Research
Institute at Nationwide Children’s Hospital and assayed for TNF-a using
the Immulite automated chemiluminometer (Siemens Medical Solutions
Diagnostics, Los Angeles, Calif).
Serum Cytokine Concentrations
Four mililiters of whole blood was collected in a BD Vacutainer CPT
tube (Becton, Dickinson and Company, Franklin Lake, NJ) and the sample
was centrifuged at 1800g for 30minutes. The plasma fraction was collected
and stored at80C until analyzed. Cytokine concentrations (IL-1b, IL-6,
IL-8, IL-12, TNF-a, IL-13, IL-1ra, and IL-10) were determined in triplicate
using the Bio-Rad multiplex suspension array system (Bio-Rad Laborato-
ries, Hercules, Calif) per manufacturer’s instructions.Chromatin Immunoprecipitation
For 6 randomly chosen patients, the buffy coat from the centrifuged
CPT tube containing mononuclear cells was transferred to a separate
tube containing 10 mL of 1% formaldehyde in RPMI medium. Cells
were incubated for 10 minutes at 37C followed by centrifugation at
1000g for 5 minutes. Cells were washed twice with phosphate-buffered
saline and then lysed in 200 mL RIPA buffer (Sigma-Aldrich) containing
25 mmol/L of tris-HCl, pH 7.6, 150 mmol/L of NaCl, 1% NP-40, 1% so-
dium deoxycholate, and 0.1% sodium dodecyl sulfate with 10 mL of Halt
Protease Inhibitor Cocktail (Pierce, Rockford, Ill) added for each 1 mL of
buffer. Samples were placed on ice for 5 minutes before storage at80C.
Cell lysates were sonicated to shear the DNA before chromatin immu-
noprecipitation (ChIP). The Low Cell Number Immunoprecipitation Kit
(Diagenode, Liege, Belgium) was used per manufacture’s protocol to per-
form the ChIP assay. In brief, 100 mL of sheared DNA in immunoprecipi-
tation buffer supplied by the manufacturer was added to prewashed protein
A magnetic beads with anti-H3K4me3 and incubated at 4C overnight. An
aliquot of nonimmunoprecipitated DNA was used as input DNA. After
overnight incubation and 3 washes, proteinase K was added to the samples,
which were then incubated for 30 minutes at 55C. Samples were boiled
for 10 minutes and centrifuged with supernatants being collected fordiovascular Surgery c Volume 143, Number 5 1161
TABLE 1. Characteristics of infected and noninfected patients
No infection (n ¼ 76) Infection (n ¼ 16) P value
Age (mo)* 13.5 (4-36) 0.87 (0.2-5.3) .001
Weight (kg)* 7.155 (5.6-13.9) 3.48 (2.9-7.1) .001
Male (%)* 56 38 .3
Duration of hospital stay (d)* 7 (5-11) 33 (16-48) .001
Duration of hospital stay before surgery (d)* 0 (0-8) 4.5 (0-31) <.001
Duration of stay in intensive care unit (d)* 4 (3-5.5) 16 (5-38) <.001
Duration of mechanical ventilation (d)* 2 (1.5-3) 12.5 (3-29) <.001
Total duration of CPB (min)* 69 (52-105) 151 (116-195) <.001
Received intraoperative steroids (%)y 3 (n ¼ 2) 12 (n ¼ 2) .27
Received modified ultrafiltration (%)y 24 (n ¼ 18) 25 (n ¼ 4) .9
Received postoperative blood transfusion (%)y 28 (n ¼ 21) 31 (n ¼ 5) .78
Amount of blood transfused (mL/kg)* 10 (10-132) 22 (10-71) .57
RACHS-1 score* 3 (2-3) 4 (3-5.5) <.01
Mortality before hospital discharge (%) 0 (n ¼ 0) 19 (n ¼ 3) .002
CPB, Cardiopulmonary bypass; RACHS-1, Risk Adjustment in Congenital Heart Surgery. *Median values with interquartile ranges. P values determined using Mann-Whitney
rank sum test. yP values determined using Fisher exact test.
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the association of H3K4me3 histone modification with the IL-10 promoter:
human IL-10 promoter 531 to 669: forward, 50-GGGACAGCTGAA
GAGGTGGA; reverse, 30-CCTCAAAGTTCCCAAGGAGC. Percent of
H3K4me3 at IL-10 promoter was calculated as follows: %(ChIP/Total
input) ¼ 2^[Ct(input)6.6Ct(Chip)] 3 100%.
Statistical Analysis
Statistical significance for parametric data was determined using an un-
paired t test for experiments comprising 2 groups and a 1-way analysis of
variance for experiments comprising 3 or more groups. TheMann-Whitney
rank sum test was used to determine statistical significance for nonparamet-
ric data. Patients were categorized as immunoparalyzed or immunocompe-
tent and Fisher’s exact test was used to determine significance. Whole
blood assay test characteristics as well as receiver–operator curves were
computed. Statistical tests were conducted using Sigma Stat 3.0 (Aspire
Software International, Ashburn, Va), and data were plotted using Graph-
Pad Prism 5.01 (GraphPad Software, Inc, La Jolla, Calif).RESULTS
Patient Characteristics
Ninety-two patients were enrolled with a median age of
10 months (range, 6 days to 16 years), median weight of
6.8 kg (range, 1.6-76.2 kg), median duration of intensive
care unit stay of 4 days (range, 1-98 days), median days
on the ventilator of 2 (range, 1-98 days), median duration
of hospital stay of 8 days (range, 4-98 days), and an overall
mortality of 3%. The median duration of CPB for all
patients was 76 minutes (range, 20-354 minutes). Three pa-
tients required CPB more than once and 6 patients required
extracorporeal life support before discharge from the inten-
sive care unit. All 22 patients weighing less than 15 kg had
modified ultrafiltration before being weaned from CPB per
standardized protocol. Four patients received intraoperative
steroids. Twenty-six patients received blood transfusions
after CPB. Two patients had delayed sternal closure. The
median RACHS-1 score for all patients was 3 (range,
1-6). At least 1 blood sample was collected on every patient1162 The Journal of Thoracic and Cardiovascular Surwith the highest number of whole blood assays obtained on
postoperative day 1.
A total of 16 (17%) patients had positive cultures before
hospital discharge. Significant differences between patients
who had infections compared with those who did not were
consistent with other published reports2,4,14-17 (Table 1). Pa-
tients in whom infections developed were younger, weighed
less, had longer intensive care unit and hospital stays, longer
durations in the hospital before the operation, longer dura-
tions of CPB, and more complex operations. We found no
difference in the percentages of patients who received blood
transfusions or the median amount of blood transfused
between patients in whom infections developed and those
in whom they did not (Table 1). Three patients died before
hospital discharge and all had positive cultures, for a mortal-
ity rate in the infected group of 19% compared with 0%
mortality for patients with no positive cultures. Details of
the positive cultures are listed in Table E1.Whole Blood Assay on Postoperative Day 1
Patients were immune phenotyped using an ex vivo
whole blood LPS-stimulation assay. Percentages of patients
having a whole blood assay performed at each study time
point are shown in Figure 1. Whole blood ex vivo TNF-a
production was lower for all time points in patients in
whom infections developed compared with patients in
whom they did not develop (Figure 2) and reached signifi-
cance for pre-CPB (P¼ .045) and postoperative day 1 sam-
ples (P¼ .004). We next investigated whether patients who
were immunoparalyzed were at a higher risk for postopera-
tive infections. Consistent with previous reports in critically
ill pediatric patients,13 we defined immunoparalysis
as whole blood assay TNF-a production of less than
200 pg/mL. Postoperative day 1 samples were able to dis-
criminate patients for risk of postoperative infectionsgery c May 2012
FIGURE 1. Whole blood assays obtained at the study time points for infected and noninfected cohorts. Percentages are the percent of patients in a cohort
(infection or no infection) who had a sample obtained at each study time point. CPB, Cardiopulmonary bypass.
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whole blood assays, 5 (42%) of 12 patients in whom infec-
tions developed and 4 (7%) of 54 patients in whom they did
not develop were classified as immunoparalyzed. Using
a cutoff of 200 pg/mL for day 1 samples (area under the
curve, 0.75; confidence interval (CI), 0.61-0.80), the whole
blood assay had a sensitivity of 42% (CI, 15-72), specificity
of 93% (CI, 83%-98), positive predictive value of 56% (CI,
21%-86%), negative predictive value of 88% (CI, 77%-
95%), and a likelihood ratio of 5.9 for development of
a postoperative infection. Comparison of receiver–operator
curves using cutoffs ranging from 100 to 500 pg/mL did notFIGURE 2. Decreased whole blood production of TNF-a after LPS stim-
ulation in ex vivo assay before and on postoperative day 1 in patients in
whom patients developed compared with patients in whom infections did
not develop. TNF-a, tumor necrosis factor-alpha; LPS, lipopolysaccharide.
The Journal of Thoracic and Carimprove the test characteristics of the assay. These data sug-
gest that the whole blood assay with a cutoff of 200 pg/mL
is able to reasonably dichotomize patients on postoperative
day 1 as immunoparalyzed or immunocompetent and can
reliably exclude patients who are at low risk for infections.IL-10 Levels Were Increased in Immunoparalyzed
Patients
Increased IL-10 levels occur after CPB and have been as-
sociated with immunoparalysis.8 We similarly observed
that immunoparalyzed patients had significantly increased
IL-10 production (mean, 14.3 pg/mL) as compared with
the nonimmunoparalyzed cohort (mean, 6.0 pg/mL;
P ¼ .01) (Figure 3, A). We detected no difference in other
selected serum cytokines concentrations (IL-1b, IL-6,
IL-8, IL-12, TNF-a, IL-13, or IL-1ra) on postoperative
day 1 between immunoparalyzed and immunocompetent
patients (Figure 3, B). In patients who had both serum sam-
ples and whole blood assay on postoperative day 1 (9 pa-
tients with infection, 47 patients with no infection), the
serum IL-10 levels were not above 10 pg/mL in patients
who did not have infections whereas higher serum IL-10
levels correlated with lower TNF- a production in patients
who did have infections (Figure E1).CPB May Affect Histone Modifications in Blood
Mononuclear Cells
Inasmuch as prior work demonstrated that posttransla-
tional histone modification affected IL-10 expression,18diovascular Surgery c Volume 143, Number 5 1163
FIGURE 3. Increased serum IL-10 levels in patients identified as immu-
noparalyzed on postoperative day 1. Multiplex sampling on serum samples
from patients on postoperative day 1 to measure cytokine levels. A, Mean
IL-10 serum levels were more than 2-fold higher in patients classified as
immunoparalyzed compared with those not immunoparalyzed (14.3 pg/mL
vs 6.0 pg/mL;P¼ .01). B, No difference detected between immunoparalyzed
and nonimmunoparalyzed patients for other serum cytokines measured.
IL, Interleukin; TNF-a, tumor necrosis factor-alpha.
FIGURE 4. Altered posttranslational histone modification, H3K4me3, at
the IL-10 promoter after CPB. Chromatin immunoprecipitation of
H3K4me3 followed by polymerase chain reaction IL-10 promoter sites
shows a 5-fold increase in the percent of IL-10 promoter associated with
the ‘‘on’’ gene histone modification (H3K4me3) on postoperative days 1
and 3 compared with preoperative samples. Values are normalized to
each individual patient’s prebypass value set at 1 to determine fold change
for each postoperative day (postoperative day 1, n¼ 6; postoperative day 3,
n ¼ 4). IL, Interleukin; CPB, cardiopulmonary bypass.
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signature, tri-methylation of lysine 4 on histone 3
(H3K4me3), at the IL-10 promoter, thereby augmenting
IL-10 expression.
To investigate the impact of CPB on the epigenetic signa-
ture of patients, we sought to determine whether changes in
histone methylation occurred in our patients. We were able
to perform ChIP for H3K4me3 on the IL-10 promoter re-
gion in only 6 patients who had a median age of 7.5 months
(range, 3-72 months), weight 9 kg (range, 6.1-19.2 kg),
RACHS-1 score 2.5 (range, 2-6), and duration of CPB 56
minutes (range, 50-218 minutes). One patient in the cohort
had a positive culture and was immunoparalyzed. The re-
sults of the ChIP assays indicate a 5-fold increase in the
H3K4me3 ‘‘gene on’’ signature at the IL-10 promoter on
postoperative day 1 (n¼ 6) compared with prebypass signa-
tures (Figure 4). This increase persisted on postoperative
day 3 (n ¼ 4). The histone modification, H3K27, was also
altered at the IL-12p35 promoter after CPB (data not
shown) in the 2 patients of this cohort in whom we were
able to obtain adequate samples to detect changes at both1164 The Journal of Thoracic and Cardiovascular Surthe IL-10 and IL-12 loci. These novel mechanistic data sug-
gest that CPB influences the epigenetic signature at inflam-
matory gene promoters and illustrate that determining
chromatin modifications after CPB is possible in pediatric
patients. This novel approach affords the opportunity to fur-
ther delineate the mechanistic regulation of gene expression
characterizing immunoparalysis.DISCUSSION
Weused awhole blood assay that measured the functional
capacity of the immune system to respond to an ex vivo stim-
ulus (LPS), and consistent with the aim of the study, wewere
able to classify patients as either immunoparalyzed or im-
munocompetent. Immunocompetent patients (TNF-a con-
centration> 200 pg/mL), on postoperative day 1, had an
88% chance of not having a postoperative infection develop.
In contrast, immunoparalyzed patients (TNF-a concen-
tration<200 pg/mL) had 2.4-fold higher serum IL-10 levels
when compared with immunocompetent patients (Figure 3,
A), consistent with the notion that IL-10 expression plays
a pivotal role in immunoparalysis and subsequent suscepti-
bility to infections.8 Although only examined in a subpopu-
lation of our cohort, we also showed that CPB affects the
histone modifications at the IL-10 promoter (Figure 4). Al-
though this sample size was small, these novel data support
further investigation into the impact of CPB on histone
methylation. Broader ChIP sequencing should identify addi-
tional epigenetically regulated target genes.
The infection rate of 17% is in the 12% to 30% range
reported by others for children after CPB.1-3 Our cohort
with infections was significantly younger and had longer
CPB duration, most likely owing to more complex
operations as estimated by RACHS-1 scores, compared with
patients in whom infections did not develop (see Table 1).
Complications associated with postoperative infectionsgery c May 2012
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and increased duration of mechanical ventilation were also
observed. We were unable to confirm the association of
blood transfusions and increased postoperative infections
that other have shown,1,19,20 which is most likely a result
of the small number of infections noted in our cohort.
A major impact of postoperative infections was a signifi-
cant mortality rate (19%) in the infected cohort, which
accounted for all of the deaths in our study population.
Thus, our data are consistent with other reports,1-3
illustrating a need for early identification of those patients
at risk for development of postoperative infections after
CPB. The small number of patients with infections in
our cohort limits our ability to adequately determine
whether immunoparalysis is independent of the other
factors associated with postoperative infections. Although
identification of patients at low risk for having infections
after CPB may allow less exposure to antibiotics, an
additional benefit would be to stratify high-risk patients
by their immunophenotype in interventional studies target-
ing immune modulation in patients showing functional im-
mune suppression.
The association of immunoparalysis and infections has
been established in critically ill patients.5,7,13,21-23 Hall
and associates13 have shown that the reversal of immuno-
paralysis in children may prevent the development of sec-
ondary infections. Our study adds to a few others that
have investigated immunoparalysis in children, including
one that investigated the impact of immunoparalysis after
CPB.7,8,23,24 Allen and colleagues7 used flow cytometry to
detect cell surface HLA-DR expression on monocytes after
CPB and showed a decrease in HLA-DR receptors with the
lowest percent of cells expressing HLA-DR receptor occur-
ring at 72 hours after CPB. Inasmuch as monocyte deactiva-
tion is a key finding in immunoparalysis and HLA-DR
receptor downregulation reflected a ‘‘static’’ measure of
monocyte cell surface expression, we sought to investigate
a functional characteristic of immunoparalysis: the cytokine
production capacity of whole blood in response to LPS. In
principle, our findings are consistent with Allen’s findings
in that immunoparalysis was associated with increased
infections, resulting in longer lengths of stays and in our
cohort higher mortality. In a subsequent follow-up on their
cohort, Allen and colleagues8 investigated the role of IL-10
in the development of immunoparalysis and demonstrated
that ex vivo production of IL-10 after 24 hours of LPS stim-
ulation of whole blood was augmented.
Results using our whole blood assay on a larger cohort
corroborated the data presented by Allen and associates,7
inasmuch as we were also able to link immunoparalysis
with infections after CPB. Our data argue for the clinical
utility of the whole blood assay, inasmuch as it may be
more sensitive earlier in the postoperative course as we
were able to identify patients on postoperative day 1 asThe Journal of Thoracic and Caropposed to day 3. Since we detected a decreased ability
for ex vivo TNF-a production before CPB (Figure 2), we
hypothesize that with a sufficient number of patients sam-
pled before CPB we may achieve immunophenotyping
before CPB. Additionally, our assay has been validated in
other critically ill pediatric patients,13 allowing us to com-
pare our results to such populations. Our data are also con-
sistent with Allen’s findings in that immunoparalysis was
associated with increased IL-10 expression (Figure 3, A).
Hypothesizing that genetics regulating IL-10 expression
may underlie this observation, they also investigated poly-
morphisms within the IL-10 promoter, but were unable to
find a significant difference.
In a mouse model of sepsis, Wen and coworkers25 dem-
onstrated an alteration in the posttranslational histone mod-
ification, H3K4me3, which was associated with altered
cytokine production in response to LPS as characterized
by decreased proinflammatory cytokine production and, no-
tably, increased IL-10 production. Inasmuch as this pattern
of gene expression was similar to that observed in immuno-
paralysis, we investigated whether CPB had an impact on an
epigenetic ‘‘gene on’’ signature at the IL-10 promoter,
which may account for the increased IL-10 levels we found.
To determine this, we were able to obtain epigenetic signa-
tures from protein-DNA cross-linked samples from selected
patients in our cohort. There are several technical limita-
tions in determining such a chromatin-based signature in
children, which we were able to overcome for the first
time in a limited pediatric cohort. Perhaps the most signif-
icant restriction is the volume of blood available for
research purposes—and thus the total number of cells avail-
able for chromatin isolation. The methodology we used in-
cluded technical modifications that enabled this isolation
from small cell numbers via Low Cell Number Immunopre-
cipitation Kit (Diagenode, Liege, Belgium). Optimization
of antibody immunoprecipitation, IL-10 promoter site de-
termination, and polymerase chain reaction amplification
were necessary to achieve the histone methylation changes
we identified. To our knowledge, this is the first demonstra-
tion of an epigenetically regulated effect obtained from cir-
culating cells in a pediatric cohort. However, inasmuch as
the primary goal of this study was to investigate the rela-
tionship of immunoparalysis with infections, we were un-
able to directly associate the impact of changes in histone
methylation with immunoparalysis. Our data demonstrate
the feasibility of studying the impact of CPB, as well as
other inflammatory triggers, on histone modification and
the subsequent effect on simultaneously observed gene ex-
pression patterns. Another limitation to our study is the
small number of patients who had infections, thus resulting
in a wide CI for our test parameters. We are currently con-
ducting investigations within the Trial of Euglycemia in
Cardiac Surgery (NCT00443599) that is enrolling a cohort
of children undergoing CPB to better delineate thediovascular Surgery c Volume 143, Number 5 1165
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sis, and the development of infections after surgery.
In summary, our whole blood assay can categorize pedi-
atric patients as immunoparalyzed or immunocompetent on
postoperative day 1, identifying individuals at risk for the
development of infections. We have also provided novel
data suggesting that CPB may affect cytokine gene expres-
sion through an epigenetic mechanism. Further studies are
necessary to investigate the relationship between epige-
netics and immunoparalysis, as well as the ability to alter
the risk for postoperative infections in those patients identi-
fied as immunoparalyzed.
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nursing staff who assisted in sample collection while providing
excellent patient care.References
1. Costello JM, Graham DA, Morrow DF, Morrow J, Potter-Bynoe G, Sandora TJ,
et al. Risk factors for surgical site infection after cardiac surgery in children. Ann
Thorac Surg. 2010;89:1833-41; discussion 1841-2.
2. Grisaru-Soen G, Paret G, Yahav D, Boyko V, Lerner-Geva L. Nosocomial infec-
tions in pediatric cardiovascular surgery patients: a 4-year survey. Pediatr Crit
Care Med. 2009;10:202-6.
3. Mehta PA, Cunningham CK, Colella CB, Alferis G, Weiner LB. Risk factors for
sternal wound and other infections in pediatric cardiac surgery patients. Pediatr
Infect Dis J. 2000;19:1000-4.
4. Levy JH, Tanaka KA. Inflammatory response to cardiopulmonary bypass. Ann
Thorac Surg. 2003;5:S715-20.
5. Volk HD, Reinke P, Krausch D, Zuckermann H, Asadullah K, M€uller JM, et al.
Monocyte deactivation—rationale for a new therapeutic strategy in sepsis. Inten-
sive Care Med. 1996;22(Suppl 4):S474-81.
6. Volk HD, Reinke P, Docke WD. Clinical aspects: from systemic inflammation to
‘‘immunoparalysis.’’ Chem Immunol. 2000;74:162-77.
7. Allen ML, Peters MJ, Goldman A, Elliott M, James I, Callard R, et al. Early post-
operative monocyte deactivation predicts systemic inflammation and prolonged
stay in pediatric cardiac intensive care. Crit Care Med. 2002;30:1140-5.
8. Allen ML, Hoschtitzky JA, Peters MJ, Elliott M, Goldman A, James I, et al. In-
terleukin-10 and its role in clinical immunoparalysis following pediatric cardiac
surgery. Crit Care Med. 2006;34:2658-65.
9. Shanley TP, Cvijanovich N, Lin R, Allen GL, Thomas NJ, Doctor A, et al.
Genome-level longitudinal expression of signaling pathways and gene networks
in pediatric septic shock. Mol Med. 2007;13:495-508.1166 The Journal of Thoracic and Cardiovascular Sur10. Carson WF 4th, Cavassani KA, Dou Y, Kunkel SL. Epigenetic regulation of im-
mune cell functions during post-septic immunosuppression. Epigenetics. 2011;6:
8-18.
11. Jenkins KJ, Gauvreau K. Center-specific differences in mortality: preliminary
analyses using the Risk Adjustment in Congenital Heart Surgery (RACHS-1)
method. J Thorac Cardiovasc Surg. 2002;124:97-104.
12. Jenkins KJ, Gauvreau K, Newburger JW, Spray TL, Moller JH, Iezzoni LI.
Consensus-based method for risk adjustment for surgery for congenital heart
disease. J Thorac Cardiovasc Surg. 2002;123:110-8.
13. Hall MW, Knatz NL, Vetterly C, Tomarello S, Wewers MD, Volk HD, et al.
Immunoparalysis and nosocomial infection in children with multiple organ
dysfunction syndrome. Intensive Care Med. 2010;37:525-32.
14. Mrowczynski W, Wojtalik M, Zawadzka D, Sharma G, Henschke J,
Bartkowski R, et al. Infection risk factors in pediatric cardiac surgery. Asian
Cardiovasc Thorac Ann. 2002;10:329-33.
15. Brown KL, Ridout DA, Goldman AP, Hoskote A, Penny DJ. Risk factors for long
intensive care unit stay after cardiopulmonary bypass in children. Crit Care Med.
2003;31:28-33.
16. Dagan O, Cox PN, Ford-Jones L, Ponsonby J, Bohn DJ. Nosocomial infection
following cardiovascular surgery: comparison of two periods, 1987 vs. 1992.
Crit Care Med. 1999;27:104-8.
17. Pollock EM, Ford-Jones EL, Rebeyka I, Mindorff CM, Bohn DJ, Edmonds JF,
et al. Early nosocomial infections in pediatric cardiovascular surgery patients.
Crit Care Med. 1990;18:378-84.
18. Wen H, Schaller MA, Dou Y, Hogaboam CM, Kunkel SL. Dendritic cells at the
interface of innate and acquired immunity: the role for epigenetic changes. J Leu-
koc Biol. 2007;83:439-46.
19. Costello JM, GrahamDA,MorrowDF, Potter-Bynoe G, Sandora TJ, Laussen PC.
Risk factors for central line–associated bloodstream infection in a pediatric car-
diac intensive care unit. Pediatr Crit Care Med. 2009;10:453-9.
20. Sohn AH, Schwartz JM, Yang KY, Jarvis WR, Guglielmo BJ, Weintrub PS. Risk
factors and risk adjustment for surgical site infections in pediatric cardiothoracic
surgery patients. Am J Infect Control. 2010;38:706-10.
21. Abe R, Hirasawa H, Oda S, Sadahiro T, Nakamura M,Watanabe E, et al. Up-reg-
ulation of interleukin-10 mRNA expression in peripheral leukocytes predicts
poor outcome and diminished human leukocyte antigen-DR expression onmono-
cytes in septic patients. J Surg Res. 2008;147:1-8.
22. Monneret G, Lepape A, Voirin N, Bohe J, Venet F, Debard AL, et al. Persisting
lowmonocyte human leukocyte antigen-DR expression predicts mortality in sep-
tic shock. Intensive Care Med. 2006;32:1175-83.
23. Hall MW, Gavrilin MA, Knatz NL, Duncan MD, Fernandez SA, Wewers MD.
Monocyte mRNA phenotype and adverse outcomes from pediatric multiple
organ dysfunction syndrome. Pediatr Res. 2007;62:597-603.
24. Marquardt DJ, Knatz NL, Wetterau LA, Wewers MD, Hall MW. Failure to re-
cover somatotropic axis function is associated with mortality from pediatric
sepsis-induced multiple organ dysfunction syndrome. Pediatr Crit Care Med.
2010;11:18-25.
25. Wen H, Dou Y, Hogaboam CM, Kunkel SL. Epigenetic regulation of dendritic
cell-derived interleukin-12 facilitates immunosuppression after a severe innate
immune response. Blood. 2008;111:1797-804.gery c May 2012
FIGURE E1. Attenuated TNF- a production in whole blood assay is as-
sociated with increased serum IL-10 levels. Scatter plots of serum IL-10
levels and TNF- a induction in the whole blood stimulation assay for pa-
tients with both samples obtained on day 1 (n ¼ 9 for patients in whom
an infection developed, n ¼ 47 for patients in whom an infection did not
develop). IL, Interleukin; TNF-a, tumor necrosis factor-alpha.
TABLE E1. Characteristics of positive cultures
Site Organism
Postoperative day sample
was obtained
Day 1 whole blood
assay<200 pg/mL
Urine Escherichia coli 14 Yes
Blood Staphylococcus aureus 10 N/A*
Surgical site Enterobacter cloacae 3 No
Sputum Enterobacter cloacae 8 No
Urine Enterococcus faecalis 1 Yes
Sputum Serratia marcescens 1 N/A*
Sputum Enterobacter cloacaea 5 N/A*
Surgical site Pseudomonas aeruginosa 23 No
Sputum Serratia marcescens 16 No
Sputum Staphylococcus aureus 2 No
Surgical site Staphylococcus aureus 15 Yes
Sputum Enterobacter cloacae 3 No
Blood Staphylococcus aureus 2 N/A*
Blood Staphylococcus aureus 2 Yes
Blood Enterococcus faecalis 18 Yes
Sputum Pseudomonas aeruginosa 3 No
*Whole blood samples were not obtained on day 1.
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